Amygdala Inhibitory Neuron Dysfunction in Schizophrenia | Neuroscience Seminar

Added:

Schizophrenia's Impact
Genetic Candidates
Neural Imbalances
Neurexin Model
Apical ITCs
Neuregulin Effects
Therapeutic Target

Schizophrenia's Impact

0:04
Playing Section
  • 1

    Schizophrenia is a severe psychiatric disorder affecting thoughts, feelings, and behavior.

  • 2

    Symptoms include positive, negative, and cognitive categories, impacting daily life.

  • 3

    The disease has a strong genetic component with significant environmental modifiers.

Anatomy and functional role of the amygdala in emotional processing, threat detection, and social behavior.
Fundamentals of synaptic transmission, specifically the distinction between excitatory (glutamatergic) and inhibitory (GABAergic) signaling.
The clinical presentation and neurobiological hypotheses of schizophrenia, including positive, negative, and cognitive symptoms.
The methodology of using transgenic and knockout genetic mouse models to mimic human psychiatric disorders in laboratory settings.
Targeted pharmacological interventions, such as specific GABA receptor modulators, designed to restore inhibitory control in the amygdala.
The Excitation/Inhibition (E/I) imbalance theory of schizophrenia and its manifestations in other key brain regions like the prefrontal cortex.
Advanced neuromodulation techniques (e.g., optogenetics and DREADDs) used to selectively control and study interneuron excitability in vivo.
Translational biomarkers (such as EEG gamma oscillations or functional MRI connectivity) that bridge rodent model findings with clinical observations in human patients.
377 views6likes58:50@faujupiter4909Original Release: 2020-10-07

This lecture presents research demonstrating that dysfunction in amygdala inhibitory circuits, particularly involving neurexin-1 alpha and ErbB4 signaling pathways, contributes to amygdala disinhibition as a common endophenotype in schizophrenia spectrum disorders. The research uses multiple mouse models to show that both neurexin-1 alpha knockout mice and ErbB4 intercalated cell knockout mice exhibit impaired fear learning, social interaction deficits, and disrupted synaptic plasticity in amygdala circuits, suggesting that targeting amygdala intercalated cells may offer therapeutic potential for treating schizophrenia.